产前诊断与未产前诊断的胎盘植入谱系疾病母体结局及临床特征比较:系统综述与Meta分析
该系统综述与Meta分析检索截至2022年11月28日的文献,纳入31项比较产前诊断与未产前诊断胎盘植入谱系疾病的研究。产前诊断组急诊剖宫产率更低(OR 0.37)、子宫切除率更高(OR 1.98)、失血量更少(均数差-0.65)、输注红细胞单位数更少(均数差-1.96),其他结局无显著差异。作者认为产前诊断对结局有积极影响,强调产前诊断的必要性。
要点
- 产前诊断胎盘植入谱系疾病与更低的急诊剖宫产率相关(OR 0.37,95%CI 0.21-0.67)。
- 产前诊断组子宫切除率更高(OR 1.98,95%CI 1.02-3.83),失血量和输注红细胞单位数更低。
- 未产前诊断组初产妇比例更低(OR 0.14)、辅助生殖技术比例更低(OR 0.19),前置胎盘和既往剖宫产比例更高。
核心结论
- 尽管病情严重,产前诊断胎盘植入谱系疾病对结局的积极影响凸显了产前诊断的必要性。
- 合并均值可为术前准备提供参考。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Cochrane数据库和Web of Science截至2022年11月28日。
- 纳入比较产前诊断与未产前诊断胎盘植入谱系疾病临床表现的研究,最终分析31项研究。
- 主要分析采用随机效应模型,计算森林图和I2统计量,并评估研究质量和发表偏倚。
主要发现
- 产前诊断组急诊剖宫产率显著低于未产前诊断组(OR 0.37,95%CI 0.21-0.67)。
- 产前诊断组子宫切除率显著高于未产前诊断组(OR 1.98,95%CI 1.02-3.83)。
- 产前诊断组失血量均数差为-0.65(95%CI -1.17至-0.13),输注红细胞单位数均数差为-1.96(95%CI -3.25至-0.68),均低于未产前诊断组。
- 初产妇OR 0.14(95%CI 0.10-0.20)、既往剖宫产OR 6.81(95%CI 4.12-11.25)、辅助生殖技术OR 0.19(95%CI 0.06-0.61)、胎盘植入和穿透性植入OR 3.97(95%CI 2.24-7.03)、前置胎盘OR 6.81(95%CI 4.12-11.25)均具统计学显著性。
- 其他结局无显著差异。
关键数值与推荐
- 产前诊断组失血量和输注血制品单位数的合并均值倾向于低于未产前诊断组。
临床怎么用
- 作者认为产前诊断对胎盘植入谱系疾病结局有积极影响,强调产前诊断的必要性。
- 作者指出合并均值可为术前准备提供参考。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to compare maternal outcomes of prenatally and nonprenatally diagnosed placenta accreta spectrum. DATA SOURCES: A systematic literature search was performed in PubMed, the Cochrane database, and Web of Science until November 28, 2022. STUDY ELIGIBILITY CRITERIA: Studies comparing the clinical presentation of prenatally and nonprenatally diagnosed placenta accreta spectrum were included. The primary outcomes were emergent cesarean delivery, hysterectomy, blood loss volume, number of transfused blood product units, urological injury, coagulopathy, reoperation, intensive care unit admission, and maternal death. In addition, the pooled mean values for blood loss volume and the number of transfused blood product units were calculated. The secondary outcomes included maternal age, gestational age at birth, nulliparity, previous cesarean delivery, previous uterine procedure, assisted reproductive technology, placenta increta and percreta, and placenta previa. METHODS: Study screening was performed after duplicates were identified and removed. The quality of each study and the publication bias were assessed. Forest plots and I2 statistics were calculated for each study outcome for each group. The main analysis was a random-effects analysis. RESULTS: Overall, 415 abstracts and 157 full-text studies were evaluated. Moreover, 31 studies were analyzed. Prenatally diagnosed placenta accreta spectrum was associated with a significantly lower rate of emergency cesarean delivery (odds ratio, 0.37; 95% confidence interval, 0.21-0.67), higher hysterectomy rate (odds ratio, 1.98; 95% confidence interval, 1.02-3.83), lower blood loss volume (mean difference, -0.65; 95% confidence interval, -1.17 to -0.13), and lower number of transfused red blood cell units (mean difference, -1.96; 95% confidence interval, -3.25 to -0.68) compared with nonprenatally diagnosed placenta accreta spectrum. The pooled mean values for blood loss volume and the number of transfused blood product units tended to be lower in the prenatally diagnosed placenta accreta spectrum groups than in the nonprenatally diagnosed placenta accreta spectrum groups. Nulliparity (odds ratio, 0.14; 95% confidence interval, 0.10-0.20), previous cesarean delivery (odds ratio, 6.81; 95% confidence interval, 4.12-11.25), assisted reproductive technology (odds ratio, 0.19; 95% confidence interval, 0.06-0.61), placenta increta and percreta (odds ratio, 3.97; 95% confidence interval, 2.24-7.03), and placenta previa (odds ratio, 6.81; 95% confidence interval, 4.12-11.25) showed statistical significance. No significant difference was found for the other outcomes. CONCLUSION: Despite its severity, the positive effect of prenatally diagnosed placenta accreta spectrum on outcomes underscores the necessity of a prenatal diagnosis. In addition, the pooled mean values provide a preoperative preparation guideline.
引用
- Sugai S, Yamawaki K, Sekizuka T, et al. Comparison of maternal outcomes and clinical characteristics of prenatally vs nonprenatally diagnosed placenta accreta spectrum: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023. PMID: 37865220. doi:10.1016/j.ajogmf.2023.101197
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。